A randomized, open-label phase III trial evaluating low- dose vs standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy- induced nausea and vomiting in solid tumors (OLAnzaPiNE).
Ecacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
Key Abstracts/publication in Supportive Care
Chairpersons :
Dr. Raghunadharao Digumarti, Dr. Bharat Parikh
Speaker :
Dr. Mansi Shah